What is Idexx Laboratories's D&A?

Idexx Laboratories (IDXX) reported D&A of $37.68M in Q1 2026.

How has Idexx Laboratories's D&A changed year-over-year?

Idexx Laboratories's D&A increased by 10.6% year-over-year, from $34.06M to $37.68M.

What is the long-term trend for Idexx Laboratories's D&A?

Over 4 years (2021 to 2025), Idexx Laboratories's D&A has grown at a 8.5% compound annual growth rate (CAGR), from $104.6M to $145.18M.

Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.

Idexx Laboratories IDXX D&A

D&A at other companies

NeogenNEOG

$28.92M-1.5%

Quest DiagnosticsDGX

$37M-5.1%

VeracyteVCYT

$5.43M+1.3%

Labcorp HoldingsLH

$75.6M+8.6%

ZoetisZTS

——

RevvityRVTY

——

Segments

By segment

See full

CAG$130.35M+12.1%

Water segment revenue$4.76M+0.5%

LPD$4.04M+6.3%

Other financials

Income statement

See full

Revenue$1.1B+14.3%

Gross profit$722.7M+15.9%

Operating income$362.6M+14.5%

Net income$278.4M+14.7%

EPS (diluted)$3.47+17.2%

Balance sheet

See full

Cash & equivalents$200.5M+22.3%

Total debt$575.5M-22.2%

Total equity$1.6B+7.5%

Total assets$3.4B+5.3%

Cash flow

See full

Operating cash flow$266.2M+11.9%

CapEx$32.0M+6.5%

Free cash flow$234.3M+12.7%

Valuation

See full

Market cap$43.5B+2.0%

Enterprise value$43.88B+1.7%

P/E39.7×-3.6×

P/S9.8×-0.8×

Profitability

See full

Gross margin62.1%+0.8pp

Operating margin31.6%+2.5pp

Net margin24.6%+1.9pp

FCF margin24.4%+2.8pp

Returns & leverage

See full

Return on equity72.9%+13.6pp

Debt / equity0.4×-0.1×

Current ratio1.1×0.0×

Where this comes from

Reported directly by Idexx Laboratories in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Idexx Laboratories's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Idexx Laboratories's D&A?: Idexx Laboratories (IDXX) reported D&A of $37.68M in Q1 2026.
How has Idexx Laboratories's D&A changed year-over-year?: Idexx Laboratories's D&A increased by 10.6% year-over-year, from $34.06M to $37.68M.
What is the long-term trend for Idexx Laboratories's D&A?: Over 4 years (2021 to 2025), Idexx Laboratories's D&A has grown at a 8.5% compound annual growth rate (CAGR), from $104.6M to $145.18M.
What does D&A mean?: Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.